Recruiting PHASE2 INTERVENTIONAL 3-arm NCT06889753

A Clinical Trial to Investigate the Effect of Pollen Extracts on Menopausal Symptoms in Healthy Women.

A Randomized, Triple-blind, Placebo Controlled, Parallel Clinical Trial to Investigate the Effect of Pollen Extracts on Menopausal Symptoms in Healthy Women.

Sponsor: Graminex LLC

Conditions Menopausal Women

Interventions Graminex LSPE Graminex WSPE Placebo

Updated 3 times since 2025 Last updated: Nov 18, 2025 Started: Oct 29, 2025 Primary completion: Aug 31, 2026 Completion: Aug 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Menopausal Women, this trial is actively recruiting participants. The trial is conducted by Graminex LLC and has accumulated 3 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Dec 2025 — Present [monthly]

Recruiting PHASE2
Aug 2025 — Dec 2025 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Apr 2025 — Aug 2025 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Graminex LLC
KGK Science Inc.

Data source: Graminex LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, Canada